In addition, higher circulating TNF-α levels in patients with than without NAFLD-associated fibrosis were also reported in this study [51]; however, this finding should be carefully interpreted, because only two studies were included in this subgroup comparison. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.